SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (3027)11/28/1997 9:03:00 PM
From: JOHN W.  Read Replies (2) of 6136
 
"Capitol Hill Update: Pelosi Wants Treatments to Match HHS Guidelines"
Washington Blade (11/21/97), p. 17.
Just prior to the winter Congressional recess, Rep. Nancy Pelosi
(D-Calif.) introduced legislation that would place federally funded HIV
treatment programs in line with the new guidelines for HIV treatment
,released earlier this year by the Department of Health and Human
Services. The bill, which was introduced to the House on Nov. 14, gives
the Secretary of Health and Human Services authority to delineate
treatment guidelines on a regular basis, and requires federally funded
programs to conform to those guidelines. The legislation also gives the
secretary authority to designate specific therapeutic drugs as essential
to treating HIV-positive persons. State Medicaid programs and state-run
AIDS Drug Assistance Programs would then be required to provide those
drugs at the minimum. The legislation was co-sponsored by 33 other members
of the House; work will start on it when Congress returns to session in
the middle of January.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News